Free Trial

OrthoPediatrics (KIDS) Competitors

OrthoPediatrics logo
$22.46 +0.33 (+1.47%)
As of 07/3/2025 03:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

KIDS vs. NVCR, LMAT, EYE, ENOV, CNMD, AORT, CDRE, TNDM, ESTA, and LQDA

Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), Artivion (AORT), Cadre (CDRE), Tandem Diabetes Care (TNDM), Establishment Labs (ESTA), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry.

OrthoPediatrics vs. Its Competitors

OrthoPediatrics (NASDAQ:KIDS) and NovoCure (NASDAQ:NVCR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

OrthoPediatrics has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, NovoCure has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

OrthoPediatrics has a net margin of -19.15% compared to NovoCure's net margin of -26.41%. OrthoPediatrics' return on equity of -7.03% beat NovoCure's return on equity.

Company Net Margins Return on Equity Return on Assets
OrthoPediatrics-19.15% -7.03% -5.45%
NovoCure -26.41%-45.46%-13.34%

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 84.6% of NovoCure shares are held by institutional investors. 32.7% of OrthoPediatrics shares are held by insiders. Comparatively, 5.5% of NovoCure shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, NovoCure had 4 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for NovoCure and 2 mentions for OrthoPediatrics. NovoCure's average media sentiment score of 0.47 beat OrthoPediatrics' score of 0.00 indicating that NovoCure is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OrthoPediatrics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NovoCure
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

OrthoPediatrics has higher earnings, but lower revenue than NovoCure. OrthoPediatrics is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OrthoPediatrics$204.73M2.67-$37.82M-$1.75-12.84
NovoCure$605.22M3.26-$168.63M-$1.51-11.73

OrthoPediatrics presently has a consensus target price of $35.83, suggesting a potential upside of 59.51%. NovoCure has a consensus target price of $32.83, suggesting a potential upside of 85.45%. Given NovoCure's higher probable upside, analysts clearly believe NovoCure is more favorable than OrthoPediatrics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
NovoCure
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

OrthoPediatrics and NovoCure tied by winning 8 of the 16 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KIDS vs. The Competition

MetricOrthoPediatricsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$545.96M$6.86B$5.56B$9.04B
Dividend YieldN/A1.21%5.24%4.01%
P/E Ratio-12.8426.6327.6620.25
Price / Sales2.6785.64415.41118.18
Price / CashN/A21.0936.8958.07
Price / Book1.534.748.035.67
Net Income-$37.82M$173.18M$3.18B$249.21M
7 Day Performance5.12%1.33%2.93%3.27%
1 Month Performance7.69%0.16%3.75%5.55%
1 Year Performance-27.09%23.71%35.20%21.08%

OrthoPediatrics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KIDS
OrthoPediatrics
3.9203 of 5 stars
$22.47
+1.5%
$35.83
+59.5%
-25.0%$545.96M$204.73M-12.84200
NVCR
NovoCure
3.6959 of 5 stars
$17.80
-1.1%
$32.83
+84.5%
+4.9%$2.01B$605.22M-11.791,488
LMAT
LeMaitre Vascular
2.7124 of 5 stars
$83.05
+0.6%
$97.83
+17.8%
+3.8%$1.87B$219.86M41.94490Positive News
EYE
National Vision
2.787 of 5 stars
$23.01
-0.7%
$18.67
-18.9%
+92.2%$1.83B$1.82B-69.7313,411News Coverage
ENOV
Enovis
3.548 of 5 stars
$31.36
-1.3%
$58.00
+84.9%
-24.3%$1.82B$2.11B-2.257,367Positive News
CNMD
CONMED
4.6529 of 5 stars
$52.10
-0.1%
$62.20
+19.4%
-19.5%$1.61B$1.31B13.713,900
AORT
Artivion
2.4897 of 5 stars
$31.17
-0.1%
$32.00
+2.7%
+18.8%$1.33B$388.54M-62.341,600
CDRE
Cadre
3.6843 of 5 stars
$31.94
-0.3%
$37.50
+17.4%
-5.3%$1.30B$567.56M33.622,284
TNDM
Tandem Diabetes Care
4.2182 of 5 stars
$18.64
-1.6%
$33.43
+79.3%
-57.1%$1.26B$940.20M-6.712,650Positive News
ESTA
Establishment Labs
1.2447 of 5 stars
$42.71
+4.3%
$52.40
+22.7%
+0.4%$1.18B$166.02M-13.781,018
LQDA
Liquidia Technologies
3.2446 of 5 stars
$12.46
-4.9%
$26.89
+115.8%
+2.4%$1.12B$14M-7.8950Positive News

Related Companies and Tools


This page (NASDAQ:KIDS) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners